NCT05940142 (Propo2022) is a clinical trial in Analysis of Anaesthesia Depth, sponsored by Karl Landsteiner University of Health Sciences.

Who is sponsoring NCT05940142?

NCT05940142 is sponsored by Karl Landsteiner University of Health Sciences.

What condition does NCT05940142 study?

NCT05940142 studies Analysis of Anaesthesia Depth.

Is NCT05940142 still recruiting?

NCT05940142 is currently status unknown. Last updated 11 July 2023.

Last reviewed 2023-07-11 · How we verify

NCT05940142: Propo2022

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prediction of Propofol Effect Compartment Concentrations

Status unknown Last updated 11 July 2023

What this trial tests

trial in Analysis of Anaesthesia Depth in 150 participants. Status unknown.

Timeline

1 May 2023

Primary endpoint
31 December 2024

31 May 2025

Quick facts

Lead sponsor	Karl Landsteiner University of Health Sciences
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	1 May 2023
Primary completion	31 December 2024
Estimated completion	31 May 2025
Sites	1 location across Austria

Conditions studied

Analysis of Anaesthesia Depth — all drugs for Analysis of Anaesthesia Depth →

Sponsor

Karl Landsteiner University of Health Sciences

Who can join

18 and older, any sex, with Analysis of Anaesthesia Depth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn about the prediction of the effect of Propofol by means of EEGs. The main questions it aims to answer are: * Develop models that can reliably predict the effect of Propofol * Select the most well suited model for clinical practice * Compare this model to already existing models (e.g. Schnider-model) Participants will asked to allow us to collect and use the EEG data recorded during the operations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Karl Landsteiner University of Health Sciences trials

Trials by the same sponsor.

NCT07056075 — Prevention of Desaturations Using Positive Airway Pressure or Capnometry During ERCP · NA · recruiting
NCT05173051 — Medication Intake of Solid Dosage Forms: A Risk Factor for Patients With Stroke-induced Dysphagia? · NA · completed
NCT05190718 — Register Study: Implementation of Pharyngeal Electrostimulation Therapy for the Treatment of Acute Neurogenic Dysphagia · recruiting
NCT06850519 — Genetic Risk Factors of the Sneddon Syndrome · completed
NCT05481918 — Gait-based Evaluation of Early Rehabilitation After ACL Reconstruction · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05940142 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karl Landsteiner University of Health Sciences
Last refreshed: 11 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05940142.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing